QGEN: Qiagen N.V. Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 10,061.60
Enterprise Value ($M) 11,008.46
Book Value ($M) 3,529.99
Book Value / Share 15.88
Price / Book 2.85
NCAV ($M) -286.13
NCAV / Share -1.29
Price / NCAV -35.16

Profitability (mra)
Return on Invested Capital (ROIC) 0.02
Return on Assets (ROA) 0.02
Return on Equity (ROE) 0.02

Liquidity (mrq)
Quick Ratio 1.89
Current Ratio 2.17

Balance Sheet (mrq) ($M)
Current Assets 2,454.07
Assets 6,270.20
Liabilities 2,740.20
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
11-08 13G Wellington Management Group Llp 9.49 404.21
11-07 13G BlackRock, Inc. 10.20 2.53
02-09 13G/A Massachusetts Financial Services Co /ma/ 10.50 -0.26

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-16 99,461 882,232 11.27
2025-01-15 104,183 981,475 10.61
2025-01-14 76,642 536,731 14.28
2025-01-13 119,770 1,209,901 9.90

(click for more detail)

Similar Companies
PBH – Prestige Consumer Healthcare Inc. PFE – Pfizer Inc.
PRGO – Perrigo Company plc RCUS – Arcus Biosciences, Inc.
RFL – Rafael Holdings, Inc.


Financial data and stock pages provided by
Fintel.io